merged_engineered-virus-steals-proteins-from-hiv.txt
<question_number>1</question_number>
<answer>one injection may keep H.I.V. low permanently, avoiding the difficulty of ensuring twice‑yearly lenacapavir shots</answer>
<question_number>2</question_number>
<answer>might make it harder for people to transmit H.I.V. to others</answer>
<question_number>3</question_number>
<answer>potential spread to others without their consent</answer>
<question_number>4</question_number>
<answer>it outcompetes H.I.V. by hijacking assembly and being packaged preferentially, driving viral levels down rather than targeting a single enzyme</answer>
<question_number>5</question_number>
<answer>permanent integration with possible unexpected side effects that cannot be removed</answer>
<question_number>6</question_number>
<answer>preferential packaging into viral shells yielding three times more TIPs than H.I.V.</answer>
<question_number>7</question_number>
<answer>irreversible insertion into DNA with side effects that cannot be undone</answer>
<question_number>8</question_number>
<answer>the cheating‑virus strategy could, in principle, work against other viruses</answer>
<question_number>9</question_number>
<answer>consent cannot be obtained from people who might be secondarily infected by TIPs</answer>
<question_number>10</question_number>
<answer>TIPs act as a molecular mimic that integrates and replicates at H.I.V.’s expense, while protease inhibitors block the viral protease</answer>